Repeated exposure to an MF-59 adjuvanted quadrivalent subunit influenza vaccine (aQIV) in children: Results of two revaccination studies

by Timo Vesikari, K. Ramsey, P. Pitisuttithum, R. Capeding, Esther Heijnen, Daphne Sawlwin, Janine Oberyé, Bin Zhang, Igor Smolenov
Published 2020

Immunogenicity and Safety of an MF59-adjuvanted Quadrivalent Seasonal Influenza Vaccine in Young Children at High Risk of Influenza-associated Complications: A Phase III, Randomize...

by Susanna Esposito, John Fling, Kulkanya Chokephaibulkit, Marianne De Bruijn, Janine Oberye, Bin Zhang, Jeanique Vossen, Esther Heijnen, Igor Smolenov
Published 2020

Prevention of influenza during mismatched seasons in older adults with an MF59-adjuvanted quadrivalent influenza vaccine: a randomised, controlled, multicentre, phase 3 efficacy st...

by Jiří Beran, Humberto Reynales, Airi Poder, Charles Y. Yu, Punnee Pitisuttithum, Lee Li Yuan, Wim Vermeulen, Carole Verhoeven, Brett Leav, Bin Zhang, Daphne Sawlwin, Esther Hamers-Heijnen, Jonathan Edelman, Igor Smolenov
Published 2022